Literature DB >> 18614234

Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains.

K R Abhinandan1, Andrew C R Martin.   

Abstract

In analysing protein sequence and structure, standardized numbering schemes allow comparison of features without explicit alignment. This has proved particularly valuable in the case of antibodies. The most widely used schemes (Kabat: sequence-based; Chothia: structure-based) differ only in the numbering of the complementarity determining regions (CDRs). We have analyzed the numbered annotations in the widely used Kabat database and found that approximately 10% of entries contain errors or inconsistencies. Further analysis of sequence alignments in the context of structure suggest that the sites of the insertions in some framework regions in the Kabat and Chothia schemes are incorrect. We therefore propose a corrected version of the Chothia scheme which is structurally correct throughout the CDRs and frameworks. To perform this analysis, we have developed, and made available, a tool for the automatic application of Kabat, Chothia and modified-Chothia numbering schemes and have carefully benchmarked the performance of this tool.

Mesh:

Substances:

Year:  2008        PMID: 18614234     DOI: 10.1016/j.molimm.2008.05.022

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  85 in total

1.  Antibody humanization by structure-based computational protein design.

Authors:  Yoonjoo Choi; Casey Hua; Charles L Sentman; Margaret E Ackerman; Chris Bailey-Kellogg
Journal:  MAbs       Date:  2015-08-07       Impact factor: 5.857

2.  Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.

Authors:  Minsun Hong; Peter S Lee; Ryan M B Hoffman; Xueyong Zhu; Jens C Krause; Nick S Laursen; Sung-Il Yoon; Langzhou Song; Lynda Tussey; James E Crowe; Andrew B Ward; Ian A Wilson
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging.

Authors:  Siyuan Ren; Xiang Sun; Haixing Wang; Trung Hai Nguyen; Negar Sadeghipour; Xiaochun Xu; Chi Soo Kang; Yujie Liu; Hua Xu; Ningjie Wu; Yanda Chen; Kenneth Tichauer; David D L Minh; Hyun-Soon Chong
Journal:  ChemMedChem       Date:  2018-11-26       Impact factor: 3.466

4.  Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Bryan S Briney; Scott A Smith; Christopher F Basler; James E Crowe
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

5.  Highly conserved protective epitopes on influenza B viruses.

Authors:  Cyrille Dreyfus; Nick S Laursen; Ted Kwaks; David Zuijdgeest; Reza Khayat; Damian C Ekiert; Jeong Hyun Lee; Zoltan Metlagel; Miriam V Bujny; Mandy Jongeneelen; Remko van der Vlugt; Mohammed Lamrani; Hans J W M Korse; Eric Geelen; Özcan Sahin; Martijn Sieuwerts; Just P J Brakenhoff; Ronald Vogels; Olive T W Li; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Andrew B Ward; Ian A Wilson; Jaap Goudsmit; Robert H E Friesen
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

6.  Conservation and diversity in the ultralong third heavy-chain complementarity-determining region of bovine antibodies.

Authors:  Robyn L Stanfield; Ian A Wilson; Vaughn V Smider
Journal:  Sci Immunol       Date:  2016-07-14

7.  Impact of Glycosylation on the Local Backbone Flexibility of Well-Defined IgG1-Fc Glycoforms Using Hydrogen Exchange-Mass Spectrometry.

Authors:  Apurva S More; Ronald T Toth; Solomon Z Okbazghi; C Russell Middaugh; Sangeeta B Joshi; Thomas J Tolbert; David B Volkin; David D Weis
Journal:  J Pharm Sci       Date:  2018-05-08       Impact factor: 3.534

8.  Drugena: A Fully Automated Immunoinformatics Platform for the Design of Antibody-Drug Conjugates Against Neurodegenerative Diseases.

Authors:  Louis Papageorgiou; Eleni Papakonstantinou; Constantinos Salis; Eleytheria Polychronidou; Marianna Hagidimitriou; Dimitris Maroulis; Elias Eliopoulos; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

9.  Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition.

Authors:  Cory L Brooks; Sven Müller-Loennies; Svetlana N Borisova; Lore Brade; Paul Kosma; Tomoko Hirama; C Roger Mackenzie; Helmut Brade; Stephen V Evans
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

10.  H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Authors:  Natalie J Thornburg; Heng Zhang; Sandhya Bangaru; Gopal Sapparapu; Nurgun Kose; Rebecca M Lampley; Robin G Bombardi; Yingchun Yu; Stephen Graham; Andre Branchizio; Sandra M Yoder; Michael T Rock; C Buddy Creech; Kathryn M Edwards; David Lee; Sheng Li; Ian A Wilson; Adolfo García-Sastre; Randy A Albrecht; James E Crowe
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.